Business

AIM Rule 17 and Schedule 2(g) update

Directa Plus plc has announced that Sarah Cope, a Director, was appointed as a Non-Executive Director of Eneraqua Technologies plc on 19 August 2021, and Eneraqua Technologies plc appointed liquidators on 16 March 2026 to undertake an insolvent Creditors Voluntary Liquidation. This disclosure is made pursuant to Rule 17 and Schedule 2(g) of the AIM Rules for Companies. Disclaimer*

articleDirecta Plus PlcMarch 20, 20265/company/directa-plus-plc/news/aim-rule-17-and-schedule-2g-update-3
AIM Rule 17 and Schedule 2(g) update

About this update from Directa Plus Plc

[{"type":"text","content":"\n\n20 March 2026\nDirecta Plus plc\n(\"Directa Plus\", the \"Group\" or the \"Company\")\n \nAIM Rule 17 and Schedule 2(g) update\n \nDirecta Plus (AIM: DCTA), a leading producer and supplier of graphene nanoplatelets based products for use in consumer and industrial markets, announces that the following information is being disclosed pursuant to Rule 17 and Schedule 2(g) of the AIM Rules for Companies.\n \nSarah Cope, a Director of Directa Plus, was appointed, and remains, as a Non-Executive Director of Eneraqua Technologies plc (\"Eneraqua\"), which is not connected to Directa Plus, on 19 August 2021. On 16 March 2026, Eneraqua appointed liquidators to undertake an insolvent Creditors Voluntary Liquidation of Eneraqua.\n \n \nFor further information, please contact:\n \n\n\n\n\nDirecta Plus plc\n\n\n+39 02 36714458\n\n\n\n\nGiulio Cesareo, CEO\n\n\n \n\n\n\n\nGiorgio Bonfanti, CFO\n\n\n \n\n\n\n\n \n\n\n\n\n\n\n\nSinger Capital Markets (Nominated Adviser and Broker)\n\n\n+44 20 7496 3069\n\n\n\n\nRick Thompson / Phil Davies\n\n\n\n\n\n\n\n \n\n\n\n\n\n\n\nAlma Strategic Communications (Financial PR Adviser)\n\n\n+44 20 3405 0205\n\n\n\n\nJustine James / Hannah Campbell / Rose Docherty\n\n\[email protected]\n\n\n\n\n \nAbout Directa Plus\nDirecta Plus (www.directa-plus.com) is one of the largest producers and suppliers of graphene-based products for use in consumer and industrial markets. The Company's graphene manufacturing capability uses proprietary patented technology based on a plasma super expansion process. Starting from natural graphite, each step of Directa Plus's production process - expansion, exfoliation and drying - creates graphene-based materials and hybrid graphene materials ready for a variety of uses and available in various forms such as powder, liquid and past\n \nThis proprietary production process uses a physical process, rather than a chemical process, to process graphite into pristine graphene nanoplatelets, which enables Directa Plus to offer a sustainable, non-toxic product, without unwanted by-products. Directa Plus's products are made of hybrid graphene materials and graphene nano-platelets. The products (marketed as G+®) have multiple applications due to its properties. These G+® product...

More updates from Directa Plus Plc